A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to ...

For an older person with type 2 diabetes, especially someone already at risk of frailty, a GLP 1 or SGLT 2 medicine, where ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to ...

Millions of adults remain confused about dietary requirements for people with Type 2 diabetes, with 20% believing they must ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to ...

The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to identify adults who could benefit from new drugs, ...

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as ...

Spending too long sitting raises the risk of heart disease and diabetes in people over 60, warns a major global review.

Discover how consuming mangoes, despite their sugar content, can positively influence blood glucose levels and aid in ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...